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ABSTRACT 
Objective: Nosocomial infections are acquired by immuno-compromised patients in hospitals which seem to be the serious health problem in 
recent times. Staphylococcus epidermidis, the commensal bacterium inhabiting human skin emerges as the most common opportunistic nosocomial 
pathogen due to its ability to form biofilms on medical devices. Biofilm acts as a mask against attacks from an immune system which leads in 
difficulty to eradicate. Several research works have been going on to find out the effective drug against hospital acquired infections since these 
pathogens are resistant to several antibiotics like methicillin, penicillin and amoxicillin. Using docking tools, an attempt has been made to find out 
the most potential drug against the nosocomial pathogen - Staphylococcus epidermidis.  
Methods: Using mcule online docking server, several drugs like linezolid, ceftaroline, rastomycin, vancomycin, nitrofurantoin, trimethoprim 
sulfamethoxazole, allicin and gallic acid were selected to dock against epidermin decarboxylase (Staphylococcus epidermidis). 
Results: Ceftaroline showed the lowest docking energy of -10.2 Kcal/mol against the target protein of Staphylococcus epidermidis (Table 1 and 
Figure 1) followed by Linezolid, Allcin and Rastomycin. 
Conclusion: By comparing the docking scores against the selected target, ceftaroline could be suggested as potential drug against coagulase 
negative Staphylococcus epidermidis infection. 
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A nosocomial infection is one for which there is no evidence that the 
infection was present or incubating at the time of hospital admission 
[1]. Coagulase negative Staphylococcus epidermidis is considered as the 
major frequent cause of these hospitals acquired infections other than 
Gram negative rods which remain in surgical site infections. Normally, 
it is a commensal bacterium that inhabits the human skin. In case of 
nosocomial infection, these commensals emerge as opportunistic 
pathogen. Due to increased use of antibiotics in hospitals, the strains of 
Staphylococcus epidermidis have become antibiotic resistant due to 
their ability to form biofilms, which results in chronic infection [2]. 
Biofilm acts as a mask against attacks from an immune system which 
leads in difficulty to eradicate. Several research works have been going 
on to find out the effective drug against these healthcare associated 
global infections since these pathogens are resistant to several 
antibiotics like methicillin, penicillin and amoxicillin.  
Drug discovery process is time consuming since it includes many 
preclinical and clinical trials. In spite of all these trials, there occur 
drug failures most of the time. The reason might be due to 
pharmacokinetic properties of ligands and its poor drug-likeness 
with the target protein. Hence by using computer aided docking 
tools, an attempt has been made to find out the most potential drug 
against the nosocomial pathogen - Staphylococcus epidermidis. 
Treating nosocomial infections have become very crucial nowadays. 
There are reports about the use of several antibiotics like linezolid, 
ceftaroline, rastomycin, vancomycin, nitrofurantoin and 
trimethoprim. Hence, their structures in SMILES format were 
retrieved from PubChem database. Online Marvin Sketch tool (http: 
//www. chemaxon. com/marvin/sketch/index. php) was used to 
draw the structures of the drugs for which the SMILES format was 
unavailable. The ADMET (Absorption, Distribution, Metabolism, 
Excretion and Toxicity) properties of these antibiotics were also 
checked in the PubChem database. 
Epidermin is an antimicrobial peptide that consists of unusual 
amino acid residue S: -[(Z: )- 2-aminovinyl]-D-cysteine present in 
Staphylococcus epidermidis. Oxidative decarboxylation of cysteine 
leads to post-translational modification of Epi-A which leads to 
introduction of this unusual cysteine residue [3]. Hence, previous 
studies reported that epidermin decarboxylase present in 
Staphylococcus epidermidis is the virulent factor of its infection. 
Hence its 3D crystal structure (PDB ID: 1G63) was retrieved from 
RCSB protein data bank (www. rcsb. org/pdb). 
Argus Lab (4.0) and online docking server (www. mcule. com) were 
used for docking analysis. Active sites were predicted using online 
active site prediction tool (www. scfbioiitd. res. in/dock/activesite. 
jsp). Molecular visualization of ligand and receptor interaction was 
carried out in Pymol software. 
 
Table 1: Docking results of selected drugs against target protein 
of Staphylococcus epidermidis 








Gallic acid -7.1 
Nimbin No acceptable ligand poses were found 
Emodin No acceptable ligand poses were found 
Aloin No acceptable ligand poses were found 
Meliantriol No acceptable ligand poses were found 
Gentamycin No acceptable ligand poses were found 
Azadirachtin No acceptable ligand poses were found 
 
Primary transporters of antimicrobial peptides have mainly been 
reported among Gram-positive bacteria producing bacteriocins 
themselves. For instance, S. epidermidis strains producing the 
lantibiotic epidermidin have evolved an additional protective system 
removing harmful peptides from the membrane after they have 
reached the lipid bilayer. This epidermidin resistance is mediated by 
the EpiEFG ABC transporter, which specifically binds only 
epidermidin [4]. 
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Allcin Gallic acid 
Fig. 1: Molecular interaction of target protein PDB ID: 1G63 with above antimicrobials 
 
Ceftaroline showed the lowest docking energy of -10.2 Kcal/mol 
against the target protein of Staphylococcus epidermidis (Table 1 and 
Figure 1) followed by Linezolid, Allcin and Rastomycin. 
In silico docking analysis revealed the comparative potentiality of 
antibiotics and phytochemicals as a promising source against 
nosocomial infections caused by Staphylococcus epidermidis. Out of 
seven phytochemicals and seven antibiotics screened, two 
phytochemicals and five antibiotics showed effective binding to the 
target proteins. Lower the docking score, higher is the binding 
affinity [5]. The results are effective not only for the pose 
construction and pose selection but also for virtual screening [5]. All 
the ligand molecules successfully passed the Lipinski filter, which 
shows its drug-likeliness.  
The results of in silico docking study clearly revealed that Ceftaroline 
is the most potential antibiotic showing very strong interaction with 
epidermin target proteins as evident by its least binding energy 
compared to other tested ligands. Even the phytochemicals are 
promising resource which deserves further research in order to 
combat dreadful human diseases either singly or in combination 
with the commercial antibiotics. 
Thus, the computer aided method plays a rapid and significant 
screening approach of drug discovery by selecting the lead 
molecules with good pharmacological and druggish properties in 
order to bind effectively with target protein. 
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